National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Natcher Building, Room 5AS-13A, 45 Center Drive, MSC 6500, Bethesda, Maryland 20892-6500

A -- FOLLOWUP STUDY OF PATIENTS RECEIVING ORAL PSORALEN PHOTCHEMOTHERAPY FOR PSORIASIS POC -- BetteShanahan, CONTRACT SPECIALIST, 301-594-2543 The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intends to negotiate with the Beth Israel Hospital, Boston, Massachusetts for a five-year continuation of a Followup Study of Patients Receiving Oral Psoralen Photochemotherapy for Psoriasis. The purpose of the extension is to extend the follow-up of all patients currently enrolled in the study with five more years of observation and examination in order to determine that the benefits of photochemotherapy of psoriasis continue to outweigh any risks associated with this treatment. A determination to use other than full and open competition has been made in accordance with 41 U.S.C. 253(c)(1) as set forth in FAR 6.302-1. Inherent duplication of cost to the Government and unacceptable delays in obtaining this support make competition of this requirement not feasible. This is not an announcement of the availability of a Request for Proposal. See Note 22.***** Posted 11/12/99 (W-SN400383). (0316)

Loren Data Corp. http://www.ld.com (SYN# 0007 19991116\A-0007.SOL)